These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6439114)

  • 1. Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin.
    Standiford HC; Drusano GL; Fitzpatrick B; Tatem B; Schimpff SC
    Antimicrob Agents Chemother; 1984 Sep; 26(3):339-42. PubMed ID: 6439114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.
    Van der Auwera P; Klastersky J; Lagast H; Husson M
    Antimicrob Agents Chemother; 1986 Jul; 30(1):122-6. PubMed ID: 3092729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with gram-negative septicemia.
    Martino P; Venditti M; Valente B; Mandelli F; Serra P
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):439-45. PubMed ID: 3891360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bactericidal activity of mezlocillin, ceftazidime, mezlocillin/ceftazidime and mezlocillin/amikacin against Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Van Laethem Y; Klastersky J
    Eur J Clin Microbiol; 1986 Feb; 5(1):110-4. PubMed ID: 3084239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
    Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
    Van der Auwera P; Klastersky J; Lieppe S; Husson M; Lauzon D; Lopez AP
    Antimicrob Agents Chemother; 1986 Feb; 29(2):230-4. PubMed ID: 3087276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
    Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Van Laethem Y; Lagast H; Klastersky J
    Antimicrob Agents Chemother; 1983 Mar; 23(3):435-9. PubMed ID: 6221694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
    Shyu WC; Nightingale CH; Quintiliani R
    J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
    Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
    Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Norman D; Kim KS
    Antimicrob Agents Chemother; 1985 Dec; 28(6):781-5. PubMed ID: 3909954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
    Meunier F; Snoeck R; Lagast H; Woussen F; Klastersky J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():195-201. PubMed ID: 3636334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.
    Lagast H; Klastersky J; Standiford H; Viollier A
    Infection; 1984; 12(3):190-3. PubMed ID: 6432702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
    Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of bacterial infection in acute leukemia, quadruple chemotherapy using CFX, AMK, TIPC and LCM (author's transl)].
    Yamaguchi H; Ichimaru M
    Jpn J Antibiot; 1980 Nov; 33(11):1215-22. PubMed ID: 7241796
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
    Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
    Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
    Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer.
    Faden HS; Deshpande GN; Grossi M; Surgalla M; Ettinger LJ; Freeman AI
    Med Pediatr Oncol; 1981; 9(5):501-9. PubMed ID: 7300805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.